IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

JOEL ABRAHM PEARLMAN

Allopathic & Osteopathic Physicians Ophthalmology Retina Specialist

NPI
1154430460
CMS profile
279766
Location
SACRAMENTO, CA

General Payments · PY2018–2024

$27,953.99

  • Reported across 117 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$17,566.09

51 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Retina Specialist CA All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $12,939.75 6
Food and Beverage $2,416.80 36
Travel and Lodging $2,209.54 9

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Regeneron Pharmaceuticals, Inc. $9,691.19 12
Amgen Inc. $5,937.88 12
BIOTISSUE HOLDINGS INC. $345.74 4
Regeneron Healthcare Solutions, Inc. $313.57 4
Alcon Laboratories Inc $276.10 3
Genentech USA, Inc. $256.78 3
TOPCON MEDICAL SYSTEMS, INC. $246.28 4
Apellis Pharmaceuticals, Inc. $205.00 4
Astellas Pharma US Inc $129.67 2
Harrow Eye, LLC $119.40 1
Astellas Pharma Global Development $25.63 1
Biogen, Inc. $18.85 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $1,002.08 16
PY2019 $813.93 14
PY2020 $2,415.76 5
PY2021 $178.70 3
PY2022 $1,322.30 7
PY2023 $4,655.13 21
PY2024 $17,566.09 51

Payment records · PY2024 (51)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Alcon Vision LLC $38.52 10/19/2024 Food and Beverage Undisputed 01/23/2026 1110568494 CMS
Alcon Vision LLC $101.86 11/14/2024 Food and Beverage Undisputed 01/23/2026 1110568496 CMS
Alcon Vision LLC $135.72 11/22/2024 Food and Beverage Undisputed 01/23/2026 1110568498 CMS
Amgen Inc. $29.00 03/09/2024 Food and Beverage Undisputed 01/23/2026 1117652144 CMS
Amgen Inc. $514.12 05/16/2024 Travel and Lodging Undisputed 01/23/2026 1117652146 CMS
Amgen Inc. $263.54 05/16/2024 Travel and Lodging Undisputed 01/23/2026 1117652148 CMS
Amgen Inc. $207.56 05/16/2024 Travel and Lodging Undisputed 01/23/2026 1117652150 CMS
Amgen Inc. $319.45 05/17/2024 Travel and Lodging Undisputed 01/23/2026 1117652152 CMS
Amgen Inc. $16.42 05/17/2024 Food and Beverage Undisputed 01/23/2026 1117652154 CMS
Amgen Inc. $5.24 05/17/2024 Food and Beverage Undisputed 01/23/2026 1117652156 CMS
Amgen Inc. $18.73 05/17/2024 Food and Beverage Undisputed 01/23/2026 1117652164 CMS
Amgen Inc. $84.07 06/22/2024 Food and Beverage Undisputed 01/23/2026 1111673701 CMS
Amgen Inc. $2,750.00 07/02/2024 Consulting Fee Undisputed 01/23/2026 1117652158 CMS
Amgen Inc. $1,179.75 07/02/2024 Consulting Fee Undisputed 01/23/2026 1117652160 CMS
Amgen Inc. $550.00 07/02/2024 Consulting Fee Undisputed 01/23/2026 1117652162 CMS
Apellis Pharmaceuticals, Inc. $26.23 03/15/2024 Food and Beverage Undisputed 01/23/2026 1154022991 CMS
Apellis Pharmaceuticals, Inc. $1.22 03/15/2024 Food and Beverage Undisputed 01/23/2026 1154022993 CMS
Apellis Pharmaceuticals, Inc. $156.30 06/07/2024 Food and Beverage Undisputed 01/23/2026 1154022989 CMS
Apellis Pharmaceuticals, Inc. $21.25 07/17/2024 Food and Beverage Undisputed 01/23/2026 1154022995 CMS
Astellas Pharma Global Development $25.63 05/05/2024 Food and Beverage Undisputed 01/23/2026 1132965891 CMS
Astellas Pharma US Inc $96.97 01/10/2024 Food and Beverage Undisputed 01/23/2026 1139420261 CMS
Astellas Pharma US Inc $32.70 10/29/2024 Food and Beverage Undisputed 01/23/2026 1139443294 CMS
Biogen, Inc. $18.85 06/07/2024 Food and Beverage Undisputed 01/23/2026 1104826882 CMS
BIOTISSUE HOLDINGS INC. $12.50 09/12/2024 Food and Beverage Undisputed 01/23/2026 1148786355 CMS
BIOTISSUE HOLDINGS INC. $160.37 10/10/2024 Food and Beverage Undisputed 01/23/2026 1148786399 CMS
BIOTISSUE HOLDINGS INC. $160.37 11/11/2024 Food and Beverage Undisputed 01/23/2026 1148754460 CMS
BIOTISSUE HOLDINGS INC. $12.50 11/11/2024 Food and Beverage Undisputed 01/23/2026 1148787514 CMS
Genentech USA, Inc. $26.92 01/17/2024 Food and Beverage Undisputed 01/23/2026 1133033964 CMS
Genentech USA, Inc. $26.35 05/31/2024 Food and Beverage Undisputed 01/23/2026 1133033967 CMS
Genentech USA, Inc. $203.51 10/17/2024 Food and Beverage Undisputed 01/23/2026 1133033972 CMS
Harrow Eye, LLC $119.40 07/16/2024 Food and Beverage Undisputed 01/23/2026 1145612094 CMS
Regeneron Healthcare Solutions, Inc. $22.04 01/16/2024 Food and Beverage Undisputed 01/23/2026 1114135028 CMS
Regeneron Healthcare Solutions, Inc. $158.25 04/05/2024 Food and Beverage Undisputed 01/23/2026 1114135030 CMS
Regeneron Healthcare Solutions, Inc. $112.55 07/13/2024 Food and Beverage Undisputed 01/23/2026 1114135032 CMS
Regeneron Healthcare Solutions, Inc. $20.73 09/11/2024 Food and Beverage Undisputed 01/23/2026 1114135034 CMS
Regeneron Pharmaceuticals, Inc. $35.25 09/16/2024 Travel and Lodging Undisputed 01/23/2026 1114403585 CMS
Regeneron Pharmaceuticals, Inc. $284.96 09/16/2024 Travel and Lodging Undisputed 01/23/2026 1114403587 CMS
Regeneron Pharmaceuticals, Inc. $60.96 10/11/2024 Travel and Lodging Undisputed 01/23/2026 1114403589 CMS
Regeneron Pharmaceuticals, Inc. $186.60 10/14/2024 Travel and Lodging Undisputed 01/23/2026 1114403591 CMS
Regeneron Pharmaceuticals, Inc. $337.10 10/17/2024 Travel and Lodging Undisputed 01/23/2026 1114403593 CMS
Regeneron Pharmaceuticals, Inc. $97.43 10/17/2024 Food and Beverage Undisputed 01/23/2026 1114403595 CMS
Regeneron Pharmaceuticals, Inc. $52.95 10/17/2024 Food and Beverage Undisputed 01/23/2026 1114403597 CMS
Regeneron Pharmaceuticals, Inc. $52.95 10/17/2024 Food and Beverage Undisputed 01/23/2026 1114403599 CMS
Regeneron Pharmaceuticals, Inc. $122.99 10/17/2024 Food and Beverage Undisputed 01/23/2026 1114403601 CMS
Regeneron Pharmaceuticals, Inc. $940.00 11/22/2024 Consulting Fee Undisputed 01/23/2026 1114403603 CMS
Regeneron Pharmaceuticals, Inc. $3,760.00 11/22/2024 Consulting Fee Undisputed 01/23/2026 1114403605 CMS
Regeneron Pharmaceuticals, Inc. $3,760.00 11/22/2024 Consulting Fee Undisputed 01/23/2026 1114403607 CMS
Topcon Healthcare, Inc. $91.11 09/11/2024 Food and Beverage Undisputed 01/23/2026 1145882620 CMS
Topcon Healthcare, Inc. $59.74 09/11/2024 Food and Beverage Undisputed 01/23/2026 1145882622 CMS
Topcon Healthcare, Inc. $23.93 12/09/2024 Food and Beverage Undisputed 01/23/2026 1145882624 CMS
Topcon Healthcare, Inc. $71.50 12/09/2024 Food and Beverage Undisputed 01/23/2026 1145882626 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.